Quarterly ResultMay 15, 2026, 09:32 AM
Incannex Healthcare Q3 Net Loss $16.8M; Cash $74.5M After $78.6M Share Issuance
AI Summary
Incannex Healthcare Inc. reported a net loss of $16.8 million for the nine months ended March 31, 2026, an increase from $15.3 million in the prior year. Despite increased operating losses, the company's cash and cash equivalents significantly rose to $74.5 million, primarily due to $78.6 million in proceeds from share issuances. The company also completed a 1-for-30 reverse stock split in February 2026 and anticipates funding operations for at least twelve months.
Key Highlights
- Net loss for the nine months ended March 31, 2026, was $16.8 million, up from $15.3 million YoY.
- Cash and cash equivalents increased to $74.5 million as of March 31, 2026, from $15.0 million.
- Proceeds from share issuance totaled $78.6 million for the nine months ended March 31, 2026.
- Net cash used in operating activities increased to $16.2 million from $11.0 million YoY.
- A 1-for-30 reverse stock split was effected on February 26, 2026.
- Weighted average shares outstanding increased to 11.45 million from 0.61 million YoY.
- Net loss per share decreased to $1.51 from $25.39 YoY, post-split adjustment.
- Company expects to fund operations for at least 12 months with current cash.
Price Impact
More from IXHL